Home Top Movers Why The GALT Stock Rose Nearly 35% During Last Session?

Why The GALT Stock Rose Nearly 35% During Last Session?

At the end of Tuesday’s regular trading session, Galectin Therapeutics Inc. (NASDAQ: GALT) closed its shares at $1.80 up 34.85% or $0.73. The Galectin stock recorded a high volume of 18.09 million shares, compared to the average daily volume of 304.27K shares. GALT stock skyrocketed after launching a website designed for chronic diseases.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

What is the website for?


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


The Galectin Therapeutics is dedicated to developing new therapies to help patients struggling with liver problems and cancer. GALT’s lead drug belapectin is a carbohydrate-based drug that interacts with the galectin-3 protein, which plays a role in multiple degenerative diseases, including inflammatory, fibrotic and malignant. Development revolves around the non-alcoholic steatohepatitis (NASH) with cirrhosis, the severe form of NASH-related fibrosis.

Read More

NAVIGATEnash.com, a dedicated trial website launched by Galectin Therapeutics, came online yesterday.

  • GALT’s new website is intended for the purpose of educating patients and physicians on liver cirrhosis caused by NASH.
  • NAVIGATE, the GALT’s innovative, seamless adaptive Phase 2b/3 study in NASH cirrhosis, will also be made available on the website.
  • Unfortunately, NASH cirrhosis currently has no treatment to lessen its progress and prevent more serious complications.
  • A patient and their families are invited to actively participate in the NAVIGATE Study, a clinical trial by GALT aimed at developing the first potential treatment for NASH-cirrhosis.

    Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

What GALT is eyeing on?

With the NAVIGATE Study, the goal of Galectin Therapeutics (GALT) is to prevent the development of esophageal varices, which have been linked to more serious complications of cirrhosis related to NASH.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Why Is The OPTT Stock Rising Today?

The shares of leading innovative and cost-effective ocean energy solutions provider Ocean Power Technologies Inc. (OPTT) have been trading up 3.54% in early trades...

IHT Stock Has Been Growing During Premarket Session. What Has Driven That Upward Trend?

At the premarket today, shares of InnSuites Hospitality Trust (NYSE: IHT) rose 10.43% to $2.33. The InnSuites stock gained 3.43% last trading day to finish...

In Premarket Session, Why Is SEAC Stock Rising?

Shares of SeaChange International Inc. (NASDAQ: SEAC) are trading up 11.65% to $1.15 in premarket. SEAC stock gained 1.98% to end Wednesday trading session...

Here is why Qualtrics International Inc (XM) stock surged in the after-hours on Wednesday?

Qualtrics International Inc (XM) stock started the Wednesday, April 21, 2021, in a negative mode and lost 0.059% in normal trading session but in...

ZLAB Stock Is On An Upswing Today. Why?

Today's premarket session has seen shares of Zai Lab Limited (NASDAQ:ZLAB) up 6.12% at $160.00. Last trading session, Zai Lab plunged -8.15% to finish...

IHT Stock Has Been Growing During Premarket Session. What Has Driven That Upward Trend?

At the premarket today, shares of InnSuites Hospitality Trust (NYSE: IHT) rose 10.43% to $2.33. The InnSuites stock gained 3.43% last trading day to finish...

Is There Any Reason Why ACTC Stock Is Rising Before The Market Opens Today?

ArcLight Clean Transition Corp. (NASDAQ: ACTC) shares are trading up 7.12% at $17.90 in premarket trade this morning. ArcLight stock gained 15.64% during the...

BNGO Stock Is On An Upswing Today, Why?

The premarket trading price for Bionano Genomics Inc. (NASDAQ: BNGO) was up 5.75% at $6.25. A share of Bionano stock closed at $5.91 last...

Related News

Is There Any Reason Why ACTC Stock Is Rising Before The Market Opens Today?

ArcLight Clean Transition Corp. (NASDAQ: ACTC) shares are trading up 7.12% at $17.90 in premarket trade this morning. ArcLight stock gained 15.64% during the...

BNGO Stock Is On An Upswing Today, Why?

The premarket trading price for Bionano Genomics Inc. (NASDAQ: BNGO) was up 5.75% at $6.25. A share of Bionano stock closed at $5.91 last...

Is This The Reason Behind The SCKT Stock Price Rising After-Hours?

During after-market trading, Socket Mobile Inc. (NASDAQ: SCKT) shares were up 9.99%, trading at $7.6. Socket stock appreciated by 6.31% to close Wednesday's session...

Why Evolus Inc (EOLS) stock turnaround on Wednesday, April 21, 2021?

Evolus Inc (EOLS) stock was performing well on Wednesday. It gained 11.09% in the normal trading session and closed at $11.72 per share. but...

Why Is WBT Stock Rocketing Today?

On the last check this morning, Welbilt Inc (NYSE: WBT) shares rose 21.63% to $19.01 in premarket trading. A price range between $15.1723 and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.